Skip to content

Comparison of Efficacy between Conventional Method an Adapted Method of Automated Peritoneal Dialysis in End Stage Kidney Disease Patients

Comparison of Efficacy between Conventional Method an Adapted Method of Automated Peritoneal Dialysis in End Stage Kidney Disease Patients

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20240409007
Enrollment
21
Registered
2024-04-09
Start date
2018-12-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Comparison of primary outcomes between the efficacy of APD-A and APD-C treatments included weekly clearances of urea (weekly KT/Vurea), and creatinine (CrCL, nCrCL). Adapted automated peritoneal dialysis, Adequacy of peritoneal dialysis, creatinine clearance, sodium clearance, phosphate clearance, blood pressure

Interventions

The administered PDF volume and dwell time were calculated for short cycles, a PDF volume of 600-800 ml/m2 BSA and a dwell time per cycle of 1 APEX time (30-60 minutes). For long cycles, a PDF volume
Active Comparator Procedure/Surgery,Active Comparator Procedure/Surgery
adapted automated peritoneal dialysis ,conventional automated peritoneal dialysis

Sponsors

the Chronic Kidney Disease Prevention in the Northeast of Thailand (CKDNET)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: ESKD patients currently on APD treatment at the peritoneal dialysis clinic, Srinagarind Hospital, Khon Kaen University from December 2018 to January 2020. The stable subjects who met the inclusion criteria: age >18 years; received CAPD treatment at least 3 months before or APD treatment at least one month before inclusion; had result of a PET within three months before inclusion; were free of infections in the abdominal cavity or other areas two months before inclusion; and agreed to participate in the study

Exclusion criteria

Exclusion criteria: pregnancy, abdominal wall defects, respiratory infections, cancer, or symptoms of an active heart disease

Design outcomes

Primary

MeasureTime frame
Efficacy week 12 weekly clearances of urea and creatinine

Secondary

MeasureTime frame
Ultrafiltration volume week 12 Ultrafiltration volume

Countries

Thailand

Contacts

Public ContactSirirat Anutrakulchai

Faculty of Medicine, Khon Kaen University

siriratrj@gmail.com6643363664

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026